Phase 2 Trial of CD19 Redirected Autologous T Cells
Conditions:   Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL;   Infants With Very High Risk KMT2A B-ALL;   Patients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation Intervention:   Biological: Murine CART19 Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2020 Category: Research Source Type: clinical trials

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
Condition:   Hematopoietic Stem Cell Transplant Interventions:   Drug: 2'-fucosyllactose;   Other: Placebo (2g oral glucose) Sponsor:   Children's Hospital Medical Center, Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
Condition:   HIV-Infected Individuals Intervention:   Biological: DD HST-NEETs Sponsor:   Catherine Bollard Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials

Resiliency in Older Adults Undergoing Bone Marrow Transplant
Conditions:   Leukemia;   Lymphoma;   Blood Cancer;   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia;   Non-Hodgkins Lymphoma Intervention:   Other: Bone Marrow Transplant (BMT) Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   National Institutes of Health (NIH);   National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2019 Category: Research Source Type: clinical trials

Haploidentical Bone Marrow Transplant With or Without NK Cell Infusion in AML and MDS
Conditions:   Acute Myeloid Leukemia;   Myelodysplasia Intervention:   Biological: NK cells Sponsors:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS;   Ministry of Health, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials

Haploidentical Bone Marrow Transplant With or Without NK Cell Infusion in AML and MDS
Conditions:   Acute Myeloid Leukemia;   Myelodysplasia Interventions:   Biological: Haplo BMT with NK cells;   Biological: Haplo BMT Sponsors:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS;   Ministry of Health, Italy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials